Please login first

The 1st International Electronic Conference on Biomolecules

Natural and Bio-Inspired Therapeutics for Human Diseases

Part of the International Electronic Conference on Biomolecules series
1–13 Dec 2020

Drug Discovery, Bio-inspired Therapeutics, Natural Drug Leads
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us

The Best Paper and Best Poster Award Winners have been announced.

Please see the 'Awards Winner Announcement' section for more details.

Welcome from the Chairs

Dear Colleagues,

It is with great enthusiam that we announce the 1st International Electronic Conference on Biomolecules: Natural and Bio-Inspired Therapeutics for Human Diseases (IECBM2020). The conference is organized by the MDPI open-access journal Biomolecules (Impact Factor 4.082), and will be held online from 1 to 13 December 2020.

Nature has long inspired drug discovery. While synthetic products often fail to meet clinical expectacions, natural products are highly optimized for their in vivo specific functions. The field of natural and bio-inspired therapeutics grows with every new attempt to mimic nature to produce new and succesful drugs targeting a wide variety of human diseases. This conference will provide leading scientists working in the field with an online platform on which to share their latest research and engage in exciting discussions. The main topics and sessions of the conference are:

  • The natural and bio-inspired drug universe (Session 1);
  • Derivatives of natural drugs: when chemistry allows optimization of what was created by nature (Session 2);
  • Pathways for the discovery of new bio-inspired and natural drugs and their derivatives (Session 3);
  • Repurposing of previously approved natural and bio-inspired drugs (Session 4).

This online event will bring together researchers from all over the world with no concerns of travel or other related expenditures. Participation and “attendance” to the IECBM2020 are FREE of charge.

The conference invites submissions for abstracts that will be reviewed by the conference committee. The authors of accepted contributions will be invited to submit a conference paper along with a slide or poster presentation of their work. All participants will have the opportunity to examine, explore, and critically engage with research findings published in Sciforum during the conference.

After the conference, all accepted papers will be published in the proceedings of this e-conference within a dedicated issue of the MDPI journal Proceedings. In addition, all participants will be encouraged to submit a full paper to one dedicated Special Issue in Biomolecules with a 20% discount on the Article Processing Charges (APC).

We hope that you will join this e-conference to exchange ideas, start fruitful collaborations, and make this first edition a success—the first of many.

Kind regards,

Prof. Dr. Vladimir Uversky
Prof. Dr. Prakash Kulkarni
Dr. Marc Maresca

The Chairs of the 1st International Electronic Conference on Biomolecules.

Conference Secretariat

M.Sc. Fancy Zhai
Ms. Kayla Wang
Dr. Elena Gonzalez
Email: iecbm2020@mdpi.com

Follow the conversation on Twitter with #IECBM2020

Conference Chairs

Aix-Marseille University, CNRS, Centrale Marseille, iSm2, F-13013 Marseille, France

DETAILS
Bio
Marc Maresca is currently Researcher at the Aix-Marseille Université. He was awarded his PhD in Biochemistry from the Université Paul Cézanne (France, 2003), where he worked on food contaminants termed mycotoxins. In 2003, he moved to England to work on enteropathogenic E. coli in the laboratory of Brendan Keny. He then moved back to France to continue his work on mycotoxins, studying their effects on human health. He is currently working at the Aix-Marseille Université, and his research aims to identify and develop new molecules with antimicrobial properties—natural, synthetic, and bio-inspired. He focuses on antimicrobial peptides and their mimics, as in addition to their antimicrobial effects, they can also be anti-inflammatory and anti-tumorigenic. He has published 52 papers in Q1 journals and 3 patents related to antimicrobial molecules. He also collaborates with food and pharmaceutical industries as a scientific expert and consultant.

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA,
Laboratory of New Methods in Biology, Institute for Biological Instrumentation, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia

DETAILS
Bio
Vladimir Uversky is Professor at the College of Molecular Medicine, University of South Florida. He is a biophysicist and obtained his PhD and Doctor of Science (DSc) in Physics and Mathematics at the Moscow Institute of Physics and Technology (1991) and at the Institute Experimental and Theoretical Biophysics, Russian Academy of Sciences (1998), respectively. He spent his early career investigating protein folding at the Institute of Protein Research and the Institute for Biological Instrumentation (Russia). In 1998, he moved to the University of California Santa Cruz to work on protein folding, misfolding, and protein intrinsic disorder. In 2004, he joined the Indiana School of Medicine and, in 2010, the University of South Florida, where he has since been continuing his studies on protein folding, misfolding, and intrinsically disordered proteins. Prof. Vladimir Uversky has authored over 850 scientific publications, edited numerous books, and is also serves as the editor of several scientific journals. He was included in Thomson Reuters’ list of Highly Cited Researchers in 2014–2019.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA

DETAILS
Bio
Prakash Kulkarni, PhD, is currently Research Professor at the Department of Medical Oncology & Therapeutics Research at the City of Hope National Medical Center, Duarte, California. Dr Kulkarni obtained his PhD in Biochemistry from Mangalore University, India, and conducted his postdoctoral training in cell biology at New York University. Subsequently, he has held Staff Scientist positions in the Division of Chemistry and Chemical Engineering as well as in the Division of Biology at the California Institute of Technology, and later, in the Department of Genetics at Yale University. Dr Kulkarni began his independent academic career as Assistant Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University, where he was named the Irene and Bernard L. Schwartz Scholar of the Patrick C Walsh Prostate Research Fund. He then moved to the Institute of Bioscience and Biotechnology Research at the University of Maryland, where he served as Research Associate Professor, before moving to City of Hope. Dr Kulkarni is an Editorial Board Member of several journals and is also the Associate Editor-in-Chief of Biomolecules. In addition, he is a member of the organizing committee of numerous international meetings and serves as Scientific Expert to various government and philanthropic organizations in the US, Europe, and Australia. In addition to cancer biology, he maintains a strong interest in prostate cancer as well as other solid tumors.

Conference Committee

Dipartimento di Medicina e Chirurgia, Università dell'Insubria, c/o Pad. Bassani, via JH Dunant, 5 -21100 Varese, Italy

Department of Nutrition and Food Science, Institute of Nutrition and Food Technology ‘José Mataix’, University of Granada, 18071 Granada, Spain

Pathophysiology of Vascular and Renal Damage Group, Department of Cell Biology, Physiology and Immunology, Córdoba University, Instituto Maimonides de Investigaciones Biomédicas de Córdoba, 14012 Córdoba, Spain

Department of Nephrology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece

Department for Science and Environment, Roskilde Universitetscenter, Roskilde, Denmark

Trinity College Dublin, Dublin, Ireland

Keynote Speakers

Massachusetts Institute of Technology, USA,
Wyss Institute, Harvard University, USA,
Broad Institute of MIT and Harvard, USA

DETAILS
Talk
Harnessing Synthetic Biology and Deep Learning to Fight Pandemics
Bio
Jim Collins is a bioengineering professor at MIT, the Broad Institute, and Harvard's Wyss Institute. He is one of the founders of synthetic biology and continues to advance the field through the development of novel classes of diagnostics and therapeutics. Jim is leading the Antibiotics-AI Project at MIT, and he is passionate about teaching and inspiring young people in the classroom and lab.

List of accepted submissions (25)

Id Title Authors Presentation Video Poster PDF
sciforum-038534 Thymoquinoneon protects neurons in the cerebellum of rats through mitigates oxidative stress and inflammation following high fat diet supplementation



Submitted: 06 Oct 2020

Abstract: Show Abstract
N/A N/A Show Abstract
sciforum-035464 Phytochemical and pharmacological study of Plectranthus ecklonii Benth. , , , , , , N/A Poster PDF Show Abstract
sciforum-038220 Biodegradable wet-spun fibers as delivery platforms for the bactericidal effect of the natural-origin biomolecules, cinnamon, clove and cajeput essential oils , , , , , , Video Thumbnail Poster PDF Show Abstract
sciforum-038645 Design and Synthesis of a cADPR Mimic as a Novel Tool for Monitoring the Intracellular Ca2+ concentration , , , , , , , N/A Poster PDF Show Abstract
sciforum-037478 De Novo Drug Design using Artificial Intelligence ASYNT-GAN

,

Submitted: 22 Sep 2020

Abstract: Show Abstract
, N/A Poster PDF Show Abstract

Live Online Sessions

Two live online sessions with a series of keynote and selected speakers have been programmed. During each session, the participants will have the possibility to ask questions live to our speakers.

In order to attend the live sessions, please register in the section below. The live sessions are FREE. The number of participants to the live session is limited but the recording will be made available on Sciforum shortly afterwards. Registrations with academic institutional email addresses will be prioritized.

Program Live Online Sessions

Session: Natural and Bio-Inspired Therapeutics for Human Diseases I
Session Chairs: Dr. Marc Maresca and Prof. Dr. Marta Martins
Date and time: 7 December 2020 at 14h CET

Time (CET) Speakers & Talks

14:00 – 14:20

Dr. Marc Maresca, Prof. Dr. Vladimir Uversky and Prof. Dr. Prakash Kulkarni

Welcome from the Conference Chairs

14:20 – 14:40

Selected talk 1

Padmavathi Ramanujam, Meenakshi Sundararajan Engineering College, India.

Discrimination of Acne Vulgaris With Human Scalp Hair Tissues Using FTIR-ATR Spectroscopy

14:40 – 15:00

Selected talk 2

Mohammad Abu Raihan Uddin, University of Science and Technology Chittagong (USTC), Bangladesh.

Can Phytochemicals Inhibit TNF-alpha?

15:00 – 15:20

Selected talk 3

Abdulrasheed O. Abdulrahman, King Abdulaziz University, Saudi Arabia.

Urolithin Is a Potential Modulator of Key Gut Microbes Related to Obesity.

15:20 – 15:40

Selected talk 4

Catarina S. Miranda, University of Minho, Portugal

Bactericidal Effect of Clo Loaded Onto Chitosan Microcapsules-Modified Biodegradable Hydrogel-Like Films: An Alternative for Treating Pseudomonas Aeruginosa Infections

15:40 – 15:50

Wrap up and concluding remarks, Session Chairs

Session: Natural and Bio-Inspired Therapeutics for Human Diseases II
Session Chairs: Dr. Marc Maresca and Prof. Dr. Vladimir Uversky
Date and time: 10 December 2020 at 17h CET

Time (CET) Speakers & Talks

17:00-17:40

Keynote talk

Prof. Dr. James J. Collins, Massachusetts Institute of Technology, the Broad Institute, and Harvard's Wyss Institute, USA

Harnessing Synthetic Biology and Deep Learning to Fight Pandemics

17:40-18:00

Selected talk 1

Ivan Jacobs, AI4U, Luxembourg

De Novo Drug Design using Artificial Intelligence ASYNT-GAN

18:00-18:20

Selected talk 2

Dr. María Cristina Vanrell, Universidad Nacional de Cuyo, Argentina

Ursolic Acid Promotes Clearance of Trypanosoma Cruzi Amastigotes in the Host Cell

18:20-18:40

Selected talk 3

Dr. Joanna Bojarska, Lodz University of Technology, Poland

Ultra Short Cyclo-Peptides as Bio-Inspired Therapeutics: Proline-Based 2,5-Diketopiperazines (DKP)

18:40 – 18:50

Wrap up and concluding remarks, Session Chairs

Live Online Sessions Content

In this section, you will find the recordings of the live sessions to watch, re-watch and share with your colleagues.

7 December 2020

10 December 2020

Instructions for Authors

Submission

To present your research at the IECBM2020:

  1. Create an account on Sciforum if you do not already have one, then click on ‘New Submission’ on the upper-right corner of the window, or click on ‘Submit Abstract’ at the top of this webpage.
  2. Submit an abstract in English (150–300 words) before 21 October 2020.
  3. The Conference Committee will evaluate all submitted abstracts, and authors will be notified by 30 October 2020 regarding acceptance.
  4. The authors of accepted contributions will be invited to submit a conference paper before 9 November 2020. In addition, authors will be encouraged to submit a slide, poster, and/or a video presentation of their work to accompany their manuscript (optional).
  5. All accepted manuscripts and presentations will be available online for discussion and for rating during the conference period (1–13 December 2020). After the conference, they will remain available online for reading at Sciforum.net.
  6. All accepted conference papers will be published in the proceedings of this e-conference within a dedicated issue of the MDPI journal Proceedings.
  7. Participants of this e-conference will be also encouraged to submit a full paper to a dedicated Special Issue in Biomolecules with a 20% discount on the article processing charge (APC).
Conference Paper

Conference papers must be prepared using the Proceedings template (word template here and latex template here), and following this organization:

  • Title
  • Full author names
  • Affiliations (including full postal address) and authors’ e-mail addresses
  • Abstract
  • Keywords
  • Introduction
  • Methods
  • Results and Discussion
  • Conclusions
  • (Acknowledgements)
  • References

Manuscripts should be prepared in MS Word or any other word processor and converted to PDF format before submission. The publication format will be PDF. The manuscript should be at least four pages (including figures, tables, and references). There is no page limit on the length, although authors are requested to keep their papers as concise as possible.

Please carefully read the rules outlined in the Instructions for Authors on the journal website and ensure that your manuscript submission adheres to these guidelines.

Accepted File Formats

Microsoft Word

Authors must use the Microsoft Word template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. Manuscript prepared in MS Word must be converted into a single file before submission. Please do not insert any graphics (schemes, figures, etc.) into a movable frame which can superimpose on the text and make the layout very difficult.

LaTeX

Manuscripts prepared in LaTeX must be collated into one ZIP folder (include all source files and images, so that the Conference Secretariat can recompile the submitted PDF). When preparing manuscripts in LaTeX, please use the LaTeX template file.

Presentation slides

Authors are encouraged to prepare a presentation in PowerPoint (or similar) to be displayed online along with the manuscript. Slides can be prepared the same way as for any traditional conference. They should be converted to PDF format before submission.

Video Presentations

Authors are also encouraged to submit video presentations. Videos will be available at Sciforum. The video should be no longer than 10 minutes and be prepared in one of the following formats:

  • .MOV
  • .MPEG4
  • .MP4
  • .AVI
  • .WMV
  • .MPEG-PS
  • .FLV

Posters

Posters will be available on this conference website during and after the event. Like papers presented on the conference, participants will be able to ask questions and make comments about the posters. Posters can be presented without an accompanying proceedings paper and will be available online on this website during and after the e-conference. However, they will not be added to the proceedings of the conference. For detailed instructions on how to submit a poster, please contact us at iecbm2020@mdpi.com.

Potential Conflicts of Interest

All authors must disclose all relationships or interests that could inappropriately influence or bias their work. This should be conveyed in a separate “Conflict of Interest” statement preceding the “Acknowledgments” and “References” sections at the end of the manuscript. If there are no conflicts, please state “The authors declare no conflicts of interest”. Financial support for the study must be fully disclosed under the “Acknowledgments” section.

Copyright

MDPI, the owner of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Communications paper to this conference, you retain the copyright of your paper but grant MDPI the nonexclusive right to publish this paper online via the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to that publisher (if required by the publisher).

Event Awards

The Sponsor Biomolecules offers one Best Paper Award and one Best Poster Award to our participants.

The Awards
Best Paper Award

Number of Awards Available: 1

300 CHF + publication waiver in Biomolecules Journal
Best Poster Award

Number of Awards Available: 1

300 CHF
Terms and Conditions:

Only full conference papers will be eligible for the Best Paper Award.

Evaluation Criteria:
  1. Originality / Novelty
  2. Significance of content
  3. Scientific soundness
  4. Interest to the readers
  5. English language and style
Evaluation Process:
  1. Each Evaluation Committee member will assess the criteria outlined above for each application.
  2. Presentations will be ranked from highest to lowest total score.
  3. If two or more authors get the same score, further evaluation will be carried out.
  4. Winners will be announced online after the conference.

Awards Winners Announcement

We are pleased to announce the winners of Best Paper Award and Best Poster Award of IECBM2020:

Winner:

Ursolic acid promotes clearance of Trypanosoma cruzi amastigotes in the host cell

(doi:10.3390/IECBM2020-08807)

María Cristina Vanrell, Santiago Martinez, Lucila Muñoz, Betiana Nebaí Salassa and Patricia Romano*

Winner:

Antibacterial Activity of Specialized Biomolecules

(doi:10.3390/IECBM2020-08819)

Tânia D. Tavares*, Joana C. Antunes, Jorge Padrão, Ana I. Ribeiro, Andrea Zille, M. Teresa P. Amorim, Fernando Ferreira and Helena P. Felgueiras

Special Issue

Selected Papers from the 1st International Electronic Conference on Biomolecules
Guest Editors: Dr. Marc Maresca, Prof. Dr. Vladimir Uversky, Prof. Dr. Prakash Kulkarni
Deadline for manuscript submissions: 30 June 2021

Other Special Issues in Biomolecules

Sponsors and Partners

Organizers


Media Partners

Top